Abstract:Background Definitive evidence to guide clinical practice on the principles of surgery for retroperitoneal sarcomas (RPSs) is still lacking. This study aims to summarise the available evidence to assess the relative benefits and disadvantages of an aggressive surgical approach with contiguous organ resection in patients with RPS, the association between surgical resection margins and survival outcomes, and the role of surgery in recurrent RPS. Methods We searched PubMed, the Cochrane Library, and EMBASE for relevant randomised trials and observational studies published from inception up to May 1, 2021. Prospective or retrospective studies, published in the English language, providing outcome data with surgical treatment in patients with RPS were selected. The primary outcome was overall survival (OS). Findings In total, 47 articles were analysed. There were no significant differences in the rates of OS (HR: 0.93; 95% CI: 0.83–1.03; P = 0.574) and recurrence-free survival (HR: 1.00; 95% CI: 0.74–1.27; P = 0.945) between the extended resection group and the tumour resection alone group. Organ resection did not increase postoperative mortality (OR: 1.00; 95% CI: 0.55–1.81; P = 0.997) but had a relatively higher complication rate (OR: 2.24, 95% CI: 0.94–5.34; P = 0.068). OS was higher in R0 than in R1 resection (HR: 1.34; 95% CI: 1.23–1.44; P < 0.001) and in R1 resection than in R2 resection (HR: 1.86; 95% CI: 1.35–2.36; P < 0.001). OS was also higher in R2 resection than in no surgery (HR: 1.26; 95% CI: 1.07–1.45; P < 0.001), however, subgroup analysis showed that the pooled HR in the trials reporting primary RPS was similar between the two groups (HR, 1.14; 95% CI, 0.87–1.42; P = 0.42). Surgical treatment achieves a significantly higher OS rate than does conservative treatment (HR: 2.42; 95% CI: 1.21–3.64; P < 0.001) for recurrent RPS. Conclusions For primary RPS, curative-intent en bloc resection should be aimed, and adjacent organs with evidence of direct invasion must be resected to avoid R2 resection. For recurrent RPS, surgical resection should be considered as a priority. Incomplete resection remains to have a survival benefit in select patients with unresectable recurrent RPS.

Retroperitoneal soft tissue sarcomas: Predictive factors for incomplete resection

Prognostic Factors of Retroperitoneal Soft Tissue Sarcomas: Analysis of 132 Cases

Management of Retroperitoneal Liposarcoma: A Case Report and Review of the Literature.

Survival and prognostic factors of primary retroperitoneal sarcomas after surgery: a single-center experience

Prognostic Factors Predicting the Postoperative Survival Period Following Treatment for Primary Retroperitoneal Liposarcoma

Prognostic factors of primary resected retroperitoneal soft tissue sarcoma: Analysis from a single asian tertiary center and external validation of gronchi's nomogram.

Comprehensive treatment strategy for improving surgical resection rate of retroperitoneal sarcomas: a histology-specific approach narrative review

Treatment of Locally Recurrent Soft Tissue Sarcomas of the Retroperitoneum: Report of 30 Cases

Survival Outcomes of Surgery for Retroperitoneal Sarcomas: A Systematic Review and Meta-Analysis

Molecular Markers of Proliferation, DNA Repair, and Immune Infiltration Defines High-Risk Subset of Resectable Retroperitoneal Sarcomas

Prognostic Factors in Patients with Recurrent or Metastatic Retroperitoneal Leiomyosarcoma.

Surgical management and factors associated with postoperative recurrence for retroperitoneal liposarcoma:a multivariate analysis

[Results of Surgical Treatment of Recurrent Retroperitoneal Soft Tissue Sarcomas].

Progress in Retroperitoneal Sarcoma Management: Surgical and Radiotherapy Approaches

Retroperitoneal Dedifferentiated Liposarcoma: Analysis of 61 Cases from a Large Institution.

Resection Outcomes for Primary and Local Recurrent Retroperitoneal Liposarcoma Patients

Intraoperative radiotherapy might not serve as a standard therapy for retroperitoneal liposarcoma: insights from a population-based propensity score-matched study

Risk factors for recurrence and survival in patients with primary retroperitoneal tumors.

Total retroperitoneal lipectomy improves prognosis in patients with primary retroperitoneal liposarcoma: a comparative study

Treatment algorithm and surgical outcome for primary and recurrent retroperitoneal sarcomas: A long-term single-center experience of 242 cases

Surgical Outcomes of Major Vascular Resection for Retroperitoneal Liposarcoma from a High‑volume Sarcoma Center: a Propensity Score Matching Analysis